
Natural enzymes can drive a wide range of chemical reactions, even though they are built from a set of no more than 20 amino acids. Professor Alexandria Deliz Liang of the University of Zurich and her team have made significant contributions to expanding this genetic code to create enzymes with new properties. In recognition of her innovative use of non-canonical amino acids, she is awarded the 2026 Ruzicka Prize.
What if...? This question lies at the heart of many science-fiction stories. The genre explores scientific and technological possibilities, however unlikely some may seem, and is unafraid to peer into the black box we call the future. What if space travel became part of everyday life? Or if crops were so nutrient-dense that world hunger could be eradicated?
Alexandria Deliz Liang, herself a science fiction enthusiast and someone who is easily excited by innovative ideas, is no stranger to such thought experiments. Imagining something new, at times seemingly impossible, is part of her research process. Indeed, the Florida-born chemist often finds herself facing a black box in her work in bioinorganic chemistry, particularly when it comes to the deliberate design of enzymes with new functions.

Peering into the black box
In nature, enzymes are proteins that catalyse (thus accelerate) countless chemical reactions in living organisms. Inside cells, they are typically assembled from combinations of 20 so-called canonical amino acids. Their amino-acid sequence and resulting three-dimensional structure are among the factors that determine an enzyme's function.
The range of these functions is enormous, and humans have long sought to harness them for their own purposes. In optimised form, enzymes are already widely used in industry and pharmaceutical production. Yet even these enzymes, modified through conventional mutagenesis, are still built from the same set of amino acids. This limits the scope for studying enzymes and creating new enzymatic functions. Overcoming this barrier is one of the field's central challenges.
"The challenge is that we still do not fully understand the relationship between enzyme structure and function," Deliz Liang explains. "For example, it remains difficult to predict how individual atoms or functional groups contribute to an enzyme's activity. Until now, the molecular tools needed to investigate these questions have been lacking. As a result, the development of new enzymes is often just trial and error."

A difficult molecular construction side
What if the genetic code could be expanded, if non-canonical amino acids could be reliably incorporated into enzymes, providing new insights into how enzymes work and ultimately make it possible to design new ones for specific applications, maybe also on a larger scale?
Even though expanding the genetic code with non-canonical amino acids has been possible for years, widespread use of the technology has lagged behind its promise. "The approach comes with several challenges," Deliz Liang admits.
"In nature, every step of enzyme production is precisely coordinated, much like a clockwork mechanism. To use non-canonical amino acids, they first must be introduced into a cell, and the cell must then be persuaded to incorporate these new amino acids into the desired enzyme. In other words, the cell's complex molecular machinery must be re-engineered accordingly for each new non-canonical amin acid." A complicated and time-intensive undertaking.
An expanded toolbox
In 2025, Deliz Liang's group vastly expanded the chemical space accessible with genetic code expansion by equipping bacterial cells with new molecular tools: systems, known chemically as aminoacyl-tRNA synthetase/tRNA pairs, that enable bacterial cells to recognize specific non-canonical amino acids and reliably incorporate them into desired enzymes ( Perdiguero et al. 2026 ). The researchers focused on incorporating twelve different histidine-like non-canonical amino acids, including τ-methylhistidine, a particularly intriguing amino acid that had never been successfully incorporated into proteins.

By modifying enzymes with these histidine variants, researchers can now investigate and manipulate the chemical properties of histidine - an amino acid that plays a central role in many important catalytic reactions - more precisely. "My team has done outstanding work here," Deliz Liang says proudly. "The publication is also special because all the authors were among the first members of my group. It is wonderful that everyone was involved."
From fundamental research to (academic) application
The potential of targeted enzyme engineering via non-canonical amino acids was demonstrated by the group using laccases as an example ( Fischer et al 2026 ). These copper-containing enzymes drive important processes in nature, such as the degradation of lignin, but they are also of potential interest for industrial applications (e.g., breakdown of environmental pollutants). The challenge is: bacterial laccases are easy to produce, but their catalytic activity is too low for industrial use.
Deliz Liang's group succeeded in specifically enhancing the performance of a bacterial laccase by developing a suitable aminoacyl-tRNA synthetase/tRNA pair and using it to incorporate highly hydrophobic non-canonical amino acids at a defined position within the enzyme. This enabled the researchers to dramatically increase the enzyme's catalytic activity. They were also able to chemically characterize the underlying effect, providing mechanistic insight into the observed improvement.

For her innovative use of non-canonical amino acids to better understand and control enzyme catalysis, Alexandria Deliz Liang is now awarded the 2026 Ruzicka Prize. "The prize stands for scientific excellence that is both creative and forward-looking. It is a great honour," says Deliz Liang. Yet there is no resting on her laurels.
Deliz Liang is already planning several mechanistic studies and intends to focus more strongly on the development of metalloenzymes as well as on exploring applications of the histidine derivatives. "Academic applications," she clarifies. "The goal of our mostly fundamental research is to advance the field through meaningful contributions and to generate knowledge that others can build upon. We do not develop industrial applications. That really would be science fiction."
Alexandria "Ali" Deliz Liang grew up in Florida and originally intended to major in mathematics. Inspired by the enthusiasm of her chemistry professors, however, she ultimately chose chemistry instead. She earned her PhD from MIT in 2015, where she learned "not only to be an enthusiastic scientist, but also a rigorous one." She then joined the Laboratory of Molecular Biology in Cambridge, UK, as a National Science Foundation Postdoctoral Fellow.
Later, she moved to the University of Basel as a Marie Curie Postdoctoral Fellow, a position that ultimately convinced her to pursue an academic career. In 2021, Deliz Liang was appointed tenure-track Assistant Professor of Digital Bioinorganic Chemistry at the University of Zurich. Outside the lab, she is an avid cook and science-fiction reader, and perhaps one day an author as well.